A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

(2018) Elisa Nemes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

(2018) Adam Penn-Nicholson et al.   Lancet Respiratory Medicine

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

(2018) Olivier Van Der Meeren et al.   NEW ENGLAND JOURNAL OF MEDICINE

H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial

(2017) Helen Mearns et al.   VACCINE

Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination

(2017) Deborah A. Lewinsohn et al.   Frontiers in Immunology

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population

(2017) Richard Baguma et al.   PLoS One

A Functional Role for Antibodies in Tuberculosis

(2016) Lenette L. Lu et al.   CELL

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa

(2016) André G. Loxton et al.   Clinical and Vaccine Immunology

Bacillus Calmette–Guérin (BCG) Revaccination of Adults with LatentMycobacterium tuberculosisInfection Induces Long-Lived BCG-Reactive NK Cell Responses

(2016) Sara Suliman et al.   JOURNAL OF IMMUNOLOGY

A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans

(2016) Cecilia S. Lindestam Arlehamn et al.   PLoS Pathogens

T cells and adaptive immunity toMycobacterium tuberculosisin humans

(2015) Luke D. Jasenosky et al.   IMMUNOLOGICAL REVIEWS

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

(2015) Benjamin M. Kagina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

(2015) Angelique Kany Kany Luabeya et al.   VACCINE

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting

(2015) Adam Penn-Nicholson et al.   VACCINE

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

(2015) François Spertini et al.   Lancet Respiratory Medicine

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

(2014) G. M. Knight et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

(2013) Cheryl L. Day et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Immune Response in Tuberculosis

(2013) Anne O'Garra et al.   Annual Review of Immunology

A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/orMycobacterium tuberculosis–infected Adults

(2012) Thomas J. Scriba et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+and CD8+T Cells in Adults

(2010) Brian Abel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

(2009) Thomas J. Scriba et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

(2009) L. J. Abu-Raddad et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Measures of fit in principal component and canonical variate analyses

(2008) Sugnet Gardner-Lubbe et al.   JOURNAL OF APPLIED STATISTICS

Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations

(2008) Willem A Hanekom et al.   PLOS MEDICINE